A RelA(p65) Thr505 phospho-site mutation reveals an important mechanism regulating NF-κB-dependent liver regeneration and cancer

Oncogene

Volumn 35, Issue 35, 2016, Pages 4623-4632

  Moles, A ^a   Butterworth, J A ^a   Sanchez, A ^a   Hunter, J E ^a   Leslie, J ^a   Sellier, H ^a   Tiniakos, D ^a   Cockell, S J ^a   Mann, D A ^a   Oakley, F ^a   Perkins, N D ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON TETRACHLORIDE; CXCL1 CHEMOKINE; DIETHYLNITROSAMINE; HISTONE GAMMA H2AX; HISTONE H2AX; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; MESSENGER RNA; PROTEIN P53; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR RELA; UNCLASSIFIED DRUG; RELA PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BODY WEIGHT; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION PROFILING; HOMOZYGOTE; IN VIVO STUDY; LIVER CANCER; LIVER CELL; LIVER CELL CARCINOMA; LIVER INJURY; LIVER REGENERATION; LIVER WEIGHT; MALE; MOUSE; NONHUMAN; PARTIAL HEPATECTOMY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STEATOSIS; TUMOR GROWTH; ANIMAL; CHEMICALLY INDUCED; DRUG EFFECTS; GENE TARGETING; GENETICS; HUMAN; KNOCKOUT MOUSE; LIVER TUMOR; MUTATION; PATHOLOGY; PHOSPHORYLATION;

ANIMALS; APOPTOSIS; CARBON TETRACHLORIDE; CELL PROLIFERATION; GENE KNOCK-IN TECHNIQUES; HEPATOCYTES; HUMANS; LIVER NEOPLASMS; LIVER REGENERATION; MICE; MICE, KNOCKOUT; MUTATION; NF-KAPPA B; PHOSPHORYLATION; TRANSCRIPTION FACTOR RELA;

EID: 84957616534     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2015.526     Document Type: Article

References (39)

1. Hayden MS, Ghosh S. Shared principles in NF-?B signaling. Cell 2008; 132: 344-362
2. Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell 2010; 140: 883-899
3. Kim HJ, Hawke N, Baldwin AS. NF-?B and IKK as therapeutic targets in cancer. Cell Death Differ 2006; 13: 738-747
4. Perkins ND. The diverse and complex roles of NF-?B subunits in cancer. Nat Rev Cancer 2012; 12: 121-132
5. Viatour P, Merville MP, Bours V. Chariot A. Phosphorylation of NF-?B and I?B proteins: implications in cancer and inflammation. Trends Biochem Sci 2005; 30: 43-52
6. O'Shea JM, Perkins ND. Regulation of the RelA (p65) transactivation domain. Biochem Soc Trans 2008; 36: 603-608
7. Perkins ND. Post-Translational modifications regulating the activity and function of the nuclear factor ?B pathway. Oncogene 2006; 25: 6717-6730
8. Moreno R, Sobotzik JM, Schultz C, Schmitz ML. Specification of the NF-?B transcriptional response by p65 phosphorylation and TNF-induced nuclear translocation of IKK epsilon. Nucleic Acids Res 2010; 38: 6029-6044
9. Beg AA, Baltimore D. An essential role for NF-?B in preventing TNF-Alpha-induced cell death. Science 1996; 274: 782-784
10. O'Shea JM, Perkins ND. Thr435 phosphorylation regulates RelA (p65) NF-?B subunit transactivation. Biochem J 2010; 426: 345-354
11. Campbell KJ, Witty JM, Rocha S, Perkins ND. Cisplatin mimics ARF tumor suppressor regulation of RelA (p65) nuclear factor-?B transactivation. Cancer Res 2006; 66: 929-935
12. Msaki A, Sanchez AM, Koh LF, Barre B, Rocha S, Perkins ND, et al. The role of RelA (p65) threonine 505 phosphorylation in the regulation of cell growth, survival, and migration. Mol Biol Cell 2011; 22: 3032-3040
13. Wu ZH, Miyamoto S. Induction of a pro-Apoptotic ATM-NF-?B pathway and its repression by ATR in response to replication stress. EMBO J 2008; 27: 1963-1973
14. Campbell KJ, Rocha S, Perkins ND. Active repression of antiapoptotic gene expression by RelA(p65) NF-?B. Mol Cell 2004; 13: 853-865
15. Rocha S, Campbell KJ, Perkins ND. p53-And Mdm2-independent repression of NF-?B transactivation by the ARF tumor suppressor. Mol Cell 2003; 12: 15-25
16. Rocha S, Garrett MD, Campbell KJ, Schumm K, Perkins ND. Regulation of NF-?B and p53 through activation of ATR and Chk1 by the ARF tumour suppressor. EMBO J 2005; 24: 1157-1169
17. Papa S, Bubici C, Zazzeroni F, Franzoso G. Mechanisms of liver disease: cross-Talk between the NF-?B and JNK pathways. Biol Chem 2009; 390: 965-976
18. He G, Karin M. NF-?B and STAT3-key players in liver inflammation and cancer. Cell Res 2011; 21: 159-168
19. Luedde T, Beraza N, Kotsikoris V, van Loo G, Nenci A, De Vos R, et al. Deletion of NEMO/IKK? in liver parenchymal cells causes steatohepatitis and hepatocellular carcinoma. Cancer Cell 2007; 11: 119-132
20. Robinson SM, Mann DA. Role of nuclear factor ?B in liver health and disease. Clin Sci (Lond) 2010; 118: 691-705
21. Wilson CL, Jurk D, Fullard N, Banks P, Page A, Luli S, et al. NF?B1 is a suppressor of neutrophil-driven hepatocellular carcinoma. Nat Commun 2015; 6: 6818
22. Cressman DE, Greenbaum LE, Haber BA, Taub R. Rapid activation of posthepatectomy factor/nuclear factor ?B in hepatocytes, a primary response in the regenerating liver. J Biol Chem 1994; 269: 30429-30435
23. Ringelhan M, Schmid RM, Geisler F. The NF-?B subunit RelA/p65 is dispensable for successful liver regeneration after partial hepatectomy in mice. PloS One 2012; 7: e46469
24. Gerondakis S, Grossmann M, Nakamura Y, Pohl T, Grumont R. Genetic approaches in mice to understand Rel/NF-?B and I?B function: transgenics and knockouts. Oncogene 1999; 18: 6888-6895
25. Heindryckx F, Colle I, Van Vlierberghe H. Experimental mouse models for hepatocellular carcinoma research. Int J Exp Pathol 2009; 90: 367-386
26. Seki E, Brenner DA, Karin M. A liver full of JNK: signaling in regulation of cell function and disease pathogenesis, and clinical approaches. Gastroenterology 2012; 143: 307-320
27. Papa S, Zazzeroni F, Bubici C, Jayawardena S, Alvarez K, Matsuda S, et al. Gadd45 beta mediates the NF-?B suppression of JNK signalling by targeting MKK7/JNKK2. Nat Cell Biol 2004; 6: 146-153
28. Algul H, Treiber M, Lesina M, Nakhai H, Saur D, Geisler F, et al. Pancreas-specific RelA/p65 truncation increases susceptibility of acini to inflammationassociated cell death following cerulein pancreatitis. J Clin Invest 2007; 117: 1490-1501
29. Stein SJ, Baldwin AS. Deletion of the NF-?B subunit p65/RelA in the hematopoietic compartment leads to defects in hematopoietic stem cell function. Blood 2013; 121: 5015-5024
30. Chariot A. The NF-?B-independent functions of IKK subunits in immunity and cancer. Trends Cell Biol 2009; 19: 404-413
31. Dong J, Jimi E, Zhong H, Hayden MS, Ghosh S. Repression of gene expression by unphosphorylated NF-?B p65 through epigenetic mechanisms. Genes Dev 2008; 22: 1159-1173
32. Alexander J, Torbenson M, Wu TT, Yeh MM. Non-Alcoholic fatty liver disease contributes to hepatocarcinogenesis in non-cirrhotic liver: a clinical and pathological study. J Gastroen Hepatol 2013; 28: 848-854
33. Mari M, Colell A, Morales A, Caballero F, Moles A, Fernandez A, et al. Mechanism of mitochondrial glutathione-dependent hepatocellular susceptibility to TNF despite NF-?B activation. Gastroenterology 2008; 134: 1507-1520
34. Ebrahimkhani MR, Oakley F, Murphy LB, Mann J, Moles A, Perugorria MJ, et al. Stimulating healthy tissue regeneration by targeting the 5-HT(2)B receptor in chronic liver disease. Nat Med 2011; 17: 1668-1673
35. Hunter JE, Butterworth JA, Zhao B, Sellier H, Campbell JK, Thomas HD, et al. The NF-?B subunit c-Rel regulates Bach2 tumour suppressor expression in B-cell lymphoma. Oncogene 2015; e-pub ahead of print 2 November 2015
36. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 2004; 5: R80
37. Hong F, Breitling R, McEntee CW, Wittner BS, Nemhauser JL, Chory J. RankProd: a bioconductor package for detecting differentially expressed genes in metaanalysis. Bioinformatics 2006; 22: 2825-2827
38. Du P, Kibbe WA, Lin SM. lumi: a pipeline for processing Illumina microarray. Bioinformatics 2008; 24: 1547-1548
39. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 2005; 102: 15545-15550